DK154979C - Analogifremgangsmaade til fremstilling af phenethanolaminderivater eller farmaceutisk acceptable syreadditionssalte deraf - Google Patents
Analogifremgangsmaade til fremstilling af phenethanolaminderivater eller farmaceutisk acceptable syreadditionssalte derafInfo
- Publication number
- DK154979C DK154979C DK165282A DK165282A DK154979C DK 154979 C DK154979 C DK 154979C DK 165282 A DK165282 A DK 165282A DK 165282 A DK165282 A DK 165282A DK 154979 C DK154979 C DK 154979C
- Authority
- DK
- Denmark
- Prior art keywords
- analogue
- preparation
- acid addition
- addition salts
- acceptable acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Artificial Filaments (AREA)
- Lubricants (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8107445 | 1981-04-14 | ||
| FR8107445A FR2503705A1 (fr) | 1981-04-14 | 1981-04-14 | Derives de phenethanolamine, leur preparation et leur application en therapeutique |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK165282A DK165282A (da) | 1982-10-15 |
| DK154979B DK154979B (da) | 1989-01-16 |
| DK154979C true DK154979C (da) | 1989-07-10 |
Family
ID=9257367
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK165282A DK154979C (da) | 1981-04-14 | 1982-04-13 | Analogifremgangsmaade til fremstilling af phenethanolaminderivater eller farmaceutisk acceptable syreadditionssalte deraf |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4430334A (de) |
| EP (1) | EP0063084B1 (de) |
| JP (1) | JPS57179160A (de) |
| AT (1) | ATE9330T1 (de) |
| AU (1) | AU545216B2 (de) |
| CA (1) | CA1185604A (de) |
| DE (1) | DE3260703D1 (de) |
| DK (1) | DK154979C (de) |
| ES (1) | ES511365A0 (de) |
| FI (1) | FI821288L (de) |
| FR (1) | FR2503705A1 (de) |
| GR (1) | GR75543B (de) |
| HU (1) | HU186492B (de) |
| IE (1) | IE52877B1 (de) |
| IL (1) | IL65493A (de) |
| MX (1) | MX155561A (de) |
| NO (1) | NO821192L (de) |
| NZ (1) | NZ200275A (de) |
| PT (1) | PT74744B (de) |
| ZA (1) | ZA822489B (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2534580A1 (fr) * | 1982-10-13 | 1984-04-20 | Synthelabo | Derives de phenyl-1 piperidino-2 propanol, leur preparation, et medicaments qui les contiennent |
| FR2546166B1 (fr) * | 1983-05-19 | 1985-10-25 | Synthelabo | Enantiomeres du erythro (benzyl-4 piperidino)-2 (hydroxy-4 ou benzyloxy-4 phenyl)-1 propanol, leur preparation et leur application en therapeutique |
| US4783471A (en) * | 1985-07-02 | 1988-11-08 | Merrell Dow Pharmaceuticals Inc. | N-aralkyl piperidine methanol derivatives and the uses thereof |
| US4912117A (en) * | 1985-07-02 | 1990-03-27 | Merrell Dow Pharmaceuticals Inc. | Novel chemical compounds |
| FR2672286B1 (fr) * | 1991-01-31 | 1994-11-18 | Synthelabo | Derives de 1-(4-chlorophenyl)-2-[4-(phenylmethyl)piperidin-1-yl]ethanol, leur preparation et leur application en therapeutique. |
| FR2678269B1 (fr) * | 1991-06-27 | 1995-01-13 | Synthelabo | Derives de 1-(4-chlorophenyl)-2-[4-(2-phenylethyl)piperidin-1-yl]ethanol, leur application et leur preparation en therapeutique. |
| FR2696741B1 (fr) * | 1992-10-12 | 1994-11-25 | Synthelabo | Dérivés de 1-(4-chlorophényl)-2-[4-[(4-fluorophényl)méthyl]piperidin-1-yl] éthanol, leur préparation et leur application en thérapeutique. |
| US20070048577A1 (en) * | 2005-08-30 | 2007-03-01 | The Government Of The United States Of America, As Represented By The Secretary Of The Navy Naval Re | Scalable microbial fuel cell with fluidic and stacking capabilities |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR5733M (de) * | 1966-09-27 | 1968-01-22 | ||
| DE1618010A1 (de) * | 1967-06-15 | 1970-11-05 | Thomae Gmbh Dr K | Verfahren zur Herstellung von neuen Aminoketonen |
| IE34545B1 (en) * | 1969-10-01 | 1975-06-11 | Continental Pharma | Amino-alcohols,their salts and process for preparing the same |
| AT354187B (de) * | 1976-11-22 | 1979-12-27 | Hoffmann La Roche | Fungizides mittel |
-
1981
- 1981-04-14 FR FR8107445A patent/FR2503705A1/fr active Granted
-
1982
- 1982-04-08 NZ NZ200275A patent/NZ200275A/en unknown
- 1982-04-09 DE DE8282400652T patent/DE3260703D1/de not_active Expired
- 1982-04-09 EP EP82400652A patent/EP0063084B1/de not_active Expired
- 1982-04-09 AT AT82400652T patent/ATE9330T1/de not_active IP Right Cessation
- 1982-04-09 HU HU821112A patent/HU186492B/hu not_active IP Right Cessation
- 1982-04-13 CA CA000400829A patent/CA1185604A/en not_active Expired
- 1982-04-13 MX MX192243A patent/MX155561A/es unknown
- 1982-04-13 IL IL65493A patent/IL65493A/xx unknown
- 1982-04-13 AU AU82555/82A patent/AU545216B2/en not_active Ceased
- 1982-04-13 DK DK165282A patent/DK154979C/da active
- 1982-04-13 FI FI821288A patent/FI821288L/fi not_active Application Discontinuation
- 1982-04-13 US US06/368,002 patent/US4430334A/en not_active Expired - Fee Related
- 1982-04-13 JP JP57061652A patent/JPS57179160A/ja active Granted
- 1982-04-13 NO NO821192A patent/NO821192L/no unknown
- 1982-04-13 ES ES511365A patent/ES511365A0/es active Granted
- 1982-04-13 ZA ZA822489A patent/ZA822489B/xx unknown
- 1982-04-13 GR GR67905A patent/GR75543B/el unknown
- 1982-04-13 PT PT74744A patent/PT74744B/pt unknown
- 1982-04-14 IE IE869/82A patent/IE52877B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA1185604A (en) | 1985-04-16 |
| FR2503705A1 (fr) | 1982-10-15 |
| PT74744B (fr) | 1985-01-08 |
| GR75543B (de) | 1984-07-27 |
| FR2503705B1 (de) | 1983-11-04 |
| US4430334A (en) | 1984-02-07 |
| AU545216B2 (en) | 1985-07-04 |
| JPS6124388B2 (de) | 1986-06-10 |
| FI821288A0 (fi) | 1982-04-13 |
| DK165282A (da) | 1982-10-15 |
| MX155561A (es) | 1988-03-25 |
| DK154979B (da) | 1989-01-16 |
| IE52877B1 (en) | 1988-03-30 |
| PT74744A (fr) | 1982-05-01 |
| EP0063084A1 (de) | 1982-10-20 |
| NZ200275A (en) | 1984-07-06 |
| ATE9330T1 (de) | 1984-09-15 |
| ES8304548A1 (es) | 1983-03-01 |
| JPS57179160A (en) | 1982-11-04 |
| AU8255582A (en) | 1982-10-21 |
| NO821192L (no) | 1982-10-15 |
| ZA822489B (en) | 1983-02-23 |
| HU186492B (en) | 1985-08-28 |
| FI821288L (fi) | 1982-10-15 |
| ES511365A0 (es) | 1983-03-01 |
| IE820869L (en) | 1982-10-14 |
| EP0063084B1 (de) | 1984-09-12 |
| DE3260703D1 (en) | 1984-10-18 |
| IL65493A (en) | 1985-03-31 |
| IL65493A0 (en) | 1982-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK74282A (da) | Fremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK462380A (da) | Analogifremgangsmaade til fremstilling af 2,4-diaminoquinazolin-forbindelser eller syreadditionssalte deraf | |
| DK149308C (da) | Analogifremgangs-maade til fremstilling af trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamin-derivater eller farmaceutisk acceptablesyreadditionssalte deraf | |
| DK151623C (da) | Analogifremgangsmaade til fremstilling af n-substituerede moranolinderivater eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK148795C (da) | Anologifremgangsmaade til fremstilling af 3-(2-morpholino-ethyl-amino)-5-phenyl-pyridazin eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK162842C (da) | Analogifremgangsmaade til fremstilling af 1-perfluoralkyl-2-(1,2,4-triazol-1-yl)-ethanol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK297382A (da) | Fremgangsmaade til fremstilling af 3-(3-(heteroarylalkyl)-1-indolyl)acryl-syre-derivater eller farmaceutisk acceptable salte deraf | |
| DK154979C (da) | Analogifremgangsmaade til fremstilling af phenethanolaminderivater eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK321482A (da) | Fremgangsmaade til fremstilling af 1-imidazolyl-2-phenyl-8-piperazinylphenoxy-octan-2-ol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK157451C (da) | Analogifremgangsmaade til fremstilling af 2,4-diamino-6-alkoxybenzyl-5-methylpyridooe2,3-daapyrimidiner eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK165005C (da) | Analogifremgangsmaade til fremstilling af 4,5-dihydro-4-oxofuran-2-carboxylsyrederivater eller terapeutisk acceptable salte deraf | |
| DK15282A (da) | Fremgangsmaade til fremstilling af (+)-enantiomere eller (+)(-)-racemiske 4a,9b-trans-hexahydro-1h-pyridoindol-derivater eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK148281C (da) | Analogifremgangsmaade til fremstilling af 8a-substituerede 8,8a-desoxy-8,8a-dihydrooleandomycin-forbindelser eller farmaceutiskacceptable syreadditionssalte deraf | |
| DK152427C (da) | Analogifremgangsmaade til fremstilling af 4-thiomethylpyridinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK157135C (da) | Analogifremgangsmaade til fremstilling af 1,2,4-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK160712C (da) | Analogifremgangsmaade til fremstilling af 4-acylamino-1-aza-adamantan-forbindelser | |
| DK157021C (da) | Analogifremgangsmaade til fremstilling af 2,3-polymethylen-4-oxo-4h-pyrido- eller -azepinooe1,2-aaapyrimidiner eller farmaceutisk acceptable syreadditionssalte eller kvaternaere salte deraf | |
| DK148036C (da) | Analogifremgangsmaade til fremstilling af epimere 4''-amino-erythromycin-forbindelser eller syreadditionssalte deraf | |
| DK149889C (da) | Analogifremgangsmaade til fremstilling af dibenzo(d,g)(1,3,6)dioxazocinderivater eller syreadditionssalte deraf | |
| DK160874C (da) | Analogifremgangsmaade til fremstilling af ergol-8-en- eller ergolinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK149750C (da) | Analogifremgangsmaade til fremstilling af n-alkenylmoranolin-derivater eller farmaceutiske acceptable syreadditionssalte deraf | |
| DK151021C (da) | Analogifremgangsmaade til fremstilling af 17,18-dehydro-apovincaminol-3',4',5'-trimethoxybenzoat eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK398283D0 (da) | Fremgangsmade til fremstilling af 1,4-dihydropyridinderivater eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK156652C (da) | Analogifremgangsmaade til fremstilling af pyridinyloxypropanolamin-derivater eller farmaceutiske acceptable syreadditionssalte deraf | |
| DK163660C (da) | Fremgangsmaade til fremstilling af benzylalkoholderivater eller farmaceutisk acceptable syreadditionssalte deraf |